Xiaojin Liu

744 total citations
26 papers, 585 citations indexed

About

Xiaojin Liu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiaojin Liu has authored 26 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Xiaojin Liu's work include Pituitary Gland Disorders and Treatments (3 papers), interferon and immune responses (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Xiaojin Liu is often cited by papers focused on Pituitary Gland Disorders and Treatments (3 papers), interferon and immune responses (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Xiaojin Liu collaborates with scholars based in China, Germany and United Kingdom. Xiaojin Liu's co-authors include Mingcai Li, Yanchun Zhou, Shao Bo Su, Zhigang Zhang, Yiwei Qi, Min‐Juan Xu, Guoying Zhang, Chuan Qiu, Min Li and Yan Li and has published in prestigious journals such as Scientific Reports, Journal of Investigative Dermatology and Sensors and Actuators B Chemical.

In The Last Decade

Xiaojin Liu

24 papers receiving 577 citations

Peers

Countries citing papers authored by Xiaojin Liu

Since Specialization

Citations

This map shows the geographic impact of Xiaojin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojin Liu more than expected).

Fields of papers citing papers by Xiaojin Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojin Liu. The network helps show where Xiaojin Liu may publish in the future.

Co-authorship network of co-authors of Xiaojin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojin Liu. A scholar is included among the top collaborators of Xiaojin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojin Liu. Xiaojin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrative analysis of single-cell and transcriptome sequencing with experimental validation reveals PKHD1L1 as a novel biomarker in lung adenocarcinoma 2025 ·Scientific Reports ·Xiangqian Zhang, Jie Wang, (unknown), Xiaojin Liu	1
2	Reconfigurable acoustofluidics on piezoelectric microdiaphragm arrays for ultrasensitive biomarker detection 2025 ·Sensors and Actuators B Chemical ·(unknown), Minghui Chen, Sheng Tang, Xiaojin Liu, Y.J Bi, Shaohui Zheng, Haoshen Zhu, Jingui Qian	0
3	Connexin 36 Mediated Intercellular Endoplasmic Reticulum Stress Transmission Induces SSTA Resistance in Growth Hormone Pituitary Adenoma 2024 ·International Journal of Biological Sciences ·(unknown), (unknown), (unknown), (unknown), Zhuo Zhang, Xiaojin Liu, Biao Xing, Sihan Li, (unknown), Yanchao Liu, Xingbo Li, Yiwei Qi, Kai Shu, Huaqiu Zhang, Yimin Huang, Ting Lei	3
4	Comprehensive Analysis Identified Glycosyltransferase Signature to Predict Glioma Prognosis and TAM Phenotype 2023 ·BioMed Research International ·Yiwei Qi, Wenchang Lv, Xiaojin Liu, (unknown), Biao Xing, (unknown), Zihan Wang, Yimin Huang, Kai Shu, Ting Lei	6
5	PKCθ Regulates Pituitary Adenoma Bone Invasion by Activating Osteoclast in NF-κB/IL-1β-Dependent Manner 2023 ·Cancers ·(unknown), (unknown), Zihan Wang, (unknown), Zhuo Zhang, Xiaojin Liu, Biao Xing, (unknown), Xiang Guo, Yanchao Liu, Xingbo Li, Kai Shu, Huaqiu Zhang, Yimin Huang, Ting Lei	6
6	Tumor-Associated Fibroblast-Derived Exosomal circDennd1b Promotes Pituitary Adenoma Progression by Modulating the miR-145-5p/ONECUT2 Axis and Activating the MAPK Pathway 2023 ·Cancers ·(unknown), (unknown), (unknown), (unknown), Zhuo Zhang, Xiaojin Liu, Biao Xing, Sihan Li, Xiang Guo, Yanchao Liu, Xingbo Li, Yiwei Qi, Kai Shu, Huaqiu Zhang, Yimin Huang, Ting Lei	8
7	A novel promising neuroprotective agent: Ganoderma lucidum polysaccharide 2022 ·International Journal of Biological Macromolecules ·Xiaojin Liu, Luodan Yang, Guangyao Li, Yingnan Jiang, Guoying Zhang, Jianya Ling	47
8	Differential centrifugation enhances the anti-tumor immune effect of tumor lysate-pulsed dendritic cell vaccine against glioblastoma* 2022 ·Oncology and Translational Medicine ·Xiaojin Liu, Yiwei Qi, Feng Hu, Kai Shu, Ting Lei	0
9	Clinicopathological Characteristics of Plurihormonal Pituitary Adenoma 2022 ·Frontiers in Surgery ·(unknown), Xueyan Wan, (unknown), (unknown), Xiaojin Liu, Ting Lei	6
10	Tuberculosis-Specific Antigen/Phytohemagglutinin Ratio Combined With GeneXpert MTB/RIF for Early Diagnosis of Spinal Tuberculosis: A Prospective Cohort Study 2022 ·Frontiers in Cellular and Infection Microbiology ·Yiwei Qi, Zhi‐Wei Liu, Xiaojin Liu, (unknown), Yanchao Liu, Feng Li	9
11	Two chronically misdiagnosed patients infected with Nocardia cyriacigeorgica accurately diagnosed by whole genome resequencing 2022 ·Frontiers in Cellular and Infection Microbiology ·(unknown), Xiaojin Liu, (unknown), Zhan Gao, Ruixiang Tang, (unknown), Liheng Zheng, Zhenxin Fan, (unknown)	2
12	Signal Pathways Involved in the Interaction Between Tumor-Associated Macrophages/TAMs and Glioblastoma Cells 2022 ·Frontiers in Oncology ·Xiaojin Liu, Yuan Liu, Yiwei Qi, Yimin Huang, Feng Hu, (unknown), Kai Shu, Ting Lei	16
13	Vitamin D enhances the sensitivity of breast cancer cells to the combination therapy of photodynamic therapy and paclitaxel 2022 ·Tissue and Cell ·Xiaojin Liu, (unknown), Haibin Shen	3
14	Current landscape of tumor-derived exosomal ncRNAs in glioma progression, detection, and drug resistance 2021 ·Cell Death and Disease ·Xiao He, Yiwei Qi, Xian Zhang, Xiaojin Liu, Xingbo Li, Sihan Li, Yiping Wu, Qi Zhang	35
15	Neurosurgery resumption in Wuhan during the early post-epidemic period: what should we pay attention to? 2021 ·Neurosurgical Review ·Yiwei Qi, Xiaojin Liu, Xueyan Wan, Liang Lü, Feng Hu, (unknown), Kai Zhao, Kai Shu, Ting Lei	1
16	Epidemiological and spatiotemporal analyses of HIV/AIDS prevalence among older adults in Sichuan, China between 2008 and 2019: A population-based study 2021 ·International Journal of Infectious Diseases ·(unknown), Li Liu, (unknown), Yali Zeng, Linglin Zhang, Fang He, Xiaojin Liu, Jumei Li, Qian Liu, Mengjiao Xu, (unknown), Ying Hu, (unknown), Rongsheng Luan	22
17	MRI Combined with Magnetic Resonance Cholangiopancreatography for Diagnosis of Benign and Malignant Pancreatic Intraductal Papillary Mucinous Neoplasms 2018 ·Current Medical Imaging Formerly Current Medical Imaging Reviews ·Xiaojin Liu, (unknown), (unknown), Junli Ye	5
18	Xiamenmycin Attenuates Hypertrophic Scars by Suppressing Local Inflammation and the Effects of Mechanical Stress 2013 ·Journal of Investigative Dermatology ·Xiaojin Liu, Min‐Juan Xu, (unknown), Zheng Wu, Jun Li, Xiaomei Yang, Yahui Wang, Jun Xu, Zhigang Zhang	50
19	Anti‐interleukin‐33 inhibits cigarette smoke‐induced lung inflammation in mice 2012 ·Immunology ·Chuan Qiu, Yan Li, Mingcai Li, Min Li, Xiaojin Liu, Charles McSharry, Damo Xu	59
20	Interferon-λs: the modulators of antivirus, antitumor, and immune responses 2009 ·Journal of Leukocyte Biology ·Mingcai Li, Xiaojin Liu, Yanchun Zhou, Shao Bo Su	164

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact